ATRX, DAXX, and H3.3 gene alterations were discovered in ALT-positive cancer samples, according to prior research, and some of these ALT-positive samples also displayed loss of ATRX or DAXX expression or localization 101, 114, 115. This evidence concerns the gene GPT and cancer.